This trial will evaluate the long-term safety and efficacy of difamilast ointment for treating atopic dermatitis in children.
2 Primary · 0 Secondary · Reporting Duration: 52-week study period
Experimental Treatment
500 Total Participants · 1 Treatment Group
Primary Treatment: Difamilast Ointment 1% · No Placebo Group · Phase 3
Age Any Age · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: